HCA eyeing purchase of Envision with private equity partner

John Gregory | | Health Exec | Policy & Regulations
HCA logo

For-profit hospital giant HCA is reportedly teaming with private equity firm KKR & Co. to make an offer on physician services company Envision Healthcare, with HCA acquiring Envision’s ambulatory surgery unit.

Reuters reports HCA’s proposal would essentially reverse Envision’s 2016 merger with AmSurg. The rest of the $5.1 billion Envision would be taken over by KKR. Its competition for the Envision assets include a consortium of rival private equity forms Carlyle Group and TPG Global.

Exclusive: HCA, KKR team up for Envision bid - sources

Envision said late in 2017 it was reviewing “strategic alternatives” after a disappointing earnings report attributed to a slow growth in patient demand for its services. UnitedHealth Group looked to be the likeliest buyer of the surgery unit, but the healthcare giant called off the bid after Envision sued its health insurance arm, UnitedHealthcare, over allegedly lowering payments “unilaterally” and refusing to include newly acquired Envision providers to its network.

Read more at the link below:

 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Related Content

To tell or not to tell: Do patients really need to know who—or what—writes their doctor’s notes?
CMS ends ACA special enrollment, changes deadline for signing up
Report: NIH continues to pull research grants, in violation of court orders
HHS sends 80K workers a $25K ‘voluntary’ resignation notice
More than 1,000 hospitals earn $700M opioid crisis judgment
VA planning 83,000 layoffs as part of restructuring

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.